UMD Data Collection

Permanent URI for this collectionhttp://hdl.handle.net/1903/27670

University of Maryland faculty and researchers can upload their research products in DRUM for rapid dissemination, global visibility and impact, and long-term preservation. Depositing data in DRUM can assist in compliance with data management and sharing requirements from the NSF, NIH, and other funding agencies and journals. You can also deposit code, documents, images, supplemental material, and other research products. DRUM tracks views and downloads of your research, and all DRUM records are indexed by Google and Google Scholar. Additionally, DRUM assigns permanent DOIs for your items, making it easy for other researchers to cite your work.

Submissions to the Data Collection

To add files to the UMD Data Collection, submit a new item through your associated department or program's DRUM collection and check the box indicating your upload contains a dataset.

Find more information and guidelines for depositing into the Data Collection on the University of Maryland Libraries' DRUM for Data page.

Assistance

Please direct questions regarding the UMD Data Collection or assistance in preparing and depositing data to: lib-research-data@umd.edu.

Browse

Search Results

Now showing 1 - 1 of 1
  • Item
    Supplementary materials for positive-unlabeled learning identifies vaccine candidate antigens in the malaria parasite Plasmodium falciparum
    (2023) Chou, Renee Ti; Ouattara, Amed; Adams, Matthew; Berry, Andrea A.; Takala-Harrison, Shannon; Cummings, Michael P.
    Malaria vaccine development is hampered by extensive antigenic variation and complex life stages of Plasmodium species. Vaccine development has focused on a small number of antigens identified prior to availability of the P. falciparum genome. In this study, we implement a machine learning-based reverse vaccinology approach to predict potential new malaria vaccine candidate antigens. We assemble and analyze P. falciparum proteomic, structural, functional, immunological, genomic, and transcriptomic data, and use positive-unlabeled learning to predict potential antigens based on the properties of known antigens and remaining proteins. We prioritize candidate antigens based on model performance on reference antigens with different genetic diversity and quantify the protein properties that contribute the most to identifying top candidates. Candidate antigens are characterized by gene essentiality, gene ontology, and gene expression in different life stages to inform future vaccine development. This approach provides a framework for identifying and prioritizing candidate vaccine antigens for a broad range of pathogens.